EOLS Competitors & Alternatives

Compare Evolus Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

EOLS

Main Stock
$6.74
Tradestie Score
58
Market Cap
$397.82M
Revenue Growth
0.1%
Analyst Upside
+117.6%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$2.69
$1.02B - 57 Compare
ANAB AnaptysBio, Inc. Common Stock
$59.43
$894.30M - 58 Compare
EYPT EyePoint Pharmaceuticals, Inc. Common Stock
$14.38
$890.20M - 58 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$5.03
$711.32M - 62 Compare
ESPR Esperion Therapeutics, Inc.
$3.16
$584.71M - 58 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$33.49
$543.32M - 57 Compare
SLDB Solid Biosciences Inc. Common Stock
$8.79
$457.09M - 62 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.86
$237.15M 6.2 55 Compare
BIOA BioAge Labs, Inc. Common Stock
$22.32
$212.23M - 57 Compare
MGNX MacroGenics, Inc.
$4.69
$107.45M - 63 Compare

Data updated: Jun 24, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry